首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 規章 > 沙烏地阿拉伯的醫療市場:到2012年為止的預測
產業/市場分類
製藥 (4816)
肥胖症治療 (44)
非專利藥 (129)
疫苗 (181)
神經疾病 (172)
骨頭疾病治療 (37)
動物用醫藥 (17)
處方藥 (156)
規章 (126)
感染疾病 (346)
精神病 (84)
製藥企業 (524)
糖尿病 (191)
癌症 (909)
藥物開發 (1449)
DDS (182)
OTC 非處方藥 (150)
市場調查報告書

沙烏地阿拉伯的醫療市場:到2012年為止的預測

Saudi Arabian Healthcare Market Forecast to 2012

出版商 RNCOS E-Services Pvt. Ltd.
出版日期 2011年08月 商品編碼 207072
內容資訊 英文 70 Pages
價格
本報告書已不再販售

本報告已在2012年05月05日停止出版。

更改為出版

Saudi Arabian Healthcare Forecast to 2015
出版日期 : 2012年04月
商品編碼: 235819

簡介

沙烏地阿拉伯的醫療保健相關市場,預計在2011-2013年之間年平均成長6.6%。該國政府和醫療保健相關人員也針對相關基本設備的維修,改善國民獲得醫療保健機會等積極的運作。

本報告提供沙烏地阿拉伯的醫療相關市場最新趨勢相關分析,整體疾病的發生情形,各市場(醫院服務·醫藥品·醫療器具)現況與市場成長預測(2011-2013年),各種阻礙成長要素和法規上的問題,再加上主要企業簡介,彙整以上種種資訊,為您概述為以下內容。

第1章 分析師的見解

第2章 分析方法

第3章 沙烏地阿拉伯的醫療簡介

第4章 新興市場趨勢

  • 企業整合與互相合作:日益普及
  • 電子醫療(e醫療)的重要性增加
  • 醫療專家的訓練
  • 新的醫療設施的建築
  • 醫療保險

第5章 醫院服務市場

  • 病床數
    • 衛生署(MOH)管轄醫院
    • 其他政府管轄醫院
    • 私立醫院
  • 醫院病床數需求預測(2011-2013年)
  • 醫院的使用情況和平均停留天數
  • 投資預測(2011-2013年)
  • 醫院內的人力資源

第6章 醫藥品市場

  • 市場概況
  • 進口及國內生產
  • 品牌化及學名藥品(Branded and Generic Drugs)

第7章 醫療用具市場

  • 市場概要
  • 市場的分類
  • 進口和國內生產

第8章 產業阻礙因素

  • 人員不足
  • 官僚主義和改革的延遲
  • 醫療觀光

第9章 法規環境

  • 醫療設備的法規
  • 醫藥品和藥品的法規環境

第10章 競爭環境

  • Sanofi-Aventis
  • TABUK Pharmaceutical Manufacturing
  • King Faisal Specialist Hospital and Research Centre
  • King Fahad Armed Forces Hospital
  • Saad Specialist Hospital

圖表一覽

目錄

Abstract

image1

The Government and health regulatory authorities in Saudi Arabia have been taking keen interest in the development of the country' s healthcare scenario. The major concern for the authorities has been enhancing the infrastructural process of health services in the country in order to improve their accessibility to the people. Considering the development plan and budgetary allocation made by the Government towards healthcare, it is safe to say that Saudi Arabia is moving fast towards achieving its aims.

According to our new research report, “Saudi Arabian Healthcare Market Forecast to 2012”, it is expected that the growth of the healthcare industry in the near future will be driven by various factors, including rapidly increasing population, rising prevalence of lifestyle and infectious diseases, and the lack of internationally accredited healthcare infrastructure. The pharma industry is expected to be one of the highly prolific healthcare sectors, estimated to grow at a CAGR of around 6.6% during 2011-2013. The country faces grim issues because of lifestyle diseases, such as obesity, diabetes, and cardiovascular disease. We have undertaken an extensive research and analysis on various segments of the Saudi Arabia healthcare market, which includes the Hospitals Services Industry, Pharmaceutical Industry, and Medical Devices Industry.

The baseline for optimistic future outlook of Saudi Arabia healthcare industry is the focus of the government and private players on the innovation and latest technology. Leading IT companies are heading towards the Kingdom to test new devices and procedures designed to streamline hospital procedures and improve patient care. In addition, new insurance laws that have been set up by the government mandates drug coverage, which further rises the spending to higher levels. Further, demand for hospitals and hospital beds is anticipated to rise during the next few years as the existing infrastructure is inadequate to deal with rising number of health complications in all sections of the society and every age group people. To meet the demand, the government is planning to open new hospitals in the country.

“Saudi Arabian Healthcare Market Forecast to 2012”, provides comprehensive research, objective analysis, and information about important issues of the Saudi Arabia healthcare market. It studies the healthcare industry by segmenting it into hospital services, medical devices, and pharmaceuticals. The report contains statistical and analytical information on each of these segments, covering their market size, demand, and market segmentation. It also features analysis of future directions, supplemented with facts and figures. In this way, the report serves as a useful guide for healthcare companies, government officials, consultants, and investors who are planning to enter the Saudi Arabian healthcare market.

Report Statistics

  • Publication Date: Aug, 2011
  • Total Number of Pages: 70
  • Format: Adobe Reader (PDF)

Table of Contents

1. Analyst View

2. Research Methodology

3. Saudi Arabia: Healthcare Profile

4. Emerging Market Trends

  • 4.1. Consolidation & Mutual Co-operation - Gaining Popularity
  • 4.2. Rising Importance of e-Health
  • 4.3. Training Healthcare Professionals
  • 4.4. Construction of New Healthcare Facilities
  • 4.5. Health Insurance

5. Hospital Services Market

  • 5.1. Hospital Bed Capacity
    • 5.1.1. MOH Hospitals
    • 5.1.2. Other Government Hospitals
    • 5.1.3. Private Hospitals
  • 5.2. Hospital Beds Demand Projection (2011-2013)
  • 5.3. Hospital Occupancy Rate and Average Length of Stay
  • 5.4. Investment Projection (2011-2013)
  • 5.5. Hospital Health Force

6. Pharmaceutical Market

  • 6.1. Market Overview
  • 6.2. Import and Domestic Production
  • 6.3. Branded and Generic Drugs

7. Medical Device Market

  • 7.1. Market Overview
  • 7.2. Market Segmentation
  • 7.3. Import and Domestic Production

8. Industry Restraints

  • 8.1. Staff Shortage
  • 8.2. Bureaucracy and Reform Delays
  • 8.3. Medical Tourism

9. Regulatory Environment

  • 9.1. Medical Device Regulation
  • 9.2. Pharmaceuticals and Drugs Regulatory Environment

10. Competitive Landscape

  • 10.1. Sanofi-Aventis
  • 10.2. TABUK Pharmaceutical Manufacturing
  • 10.3. King Faisal Specialist Hospital and Research Centre
  • 10.4. King Fahad Armed Forces Hospital
  • 10.5. Saad Specialist Hospital

List of Figures:

  • Figure 3-1: Breakup of Cardiovascular Disease by Category (%), 2010
  • Figure 4-1: Health Insurance Premium (Billion SAR), 2009-2013
  • Figure 5-1: Number of Hospital Beds (2007-2010)
  • Figure 5-2: Hospital Beds by Sector (%), 2010
  • Figure 5-3: Hospitals by Sector (%), 2010
  • Figure 5-4: Additional Demand of Number of Hospital Beds (2011-2013)
  • Figure 5-5: Forecast for Distribution of Incremental Bed Capacity by Sector (%), 2013
  • Figure 5-6: Investment Required for Additional Demand of Hospital Beds (Billion SAR), 2011-2013
  • Figure 5-7: Budget Allocated for Healthcare and Social Services (Billion SAR), 2009-2011
  • Figure 6-1: Pharmaceutical Market (Billion SAR), 2008-2013
  • Figure 6-2: Share of Imported and Domestically Manufactured Drugs in Pharmaceutical Market (2010)
  • Figure 6-3: Pharmaceutical Imports by Region (%), 2006
  • Figure 6-4: Breakup of Pharmaceutical Market by Drug Class (2010)
  • Figure 6-5: Share of OTC and Prescription Drugs in Pharmaceutical Market (2010)
  • Figure 7-1: Medical Device Market (Million US$), 2010-2013
  • Figure 7-2: Medical Equipment Imports by Major Categories (%) 2006
  • Figure 7-3: Medical Supplies Imports by Major Categories (%), 2006
  • Figure 7-4: Share of Imported and Domestically Manufactured Devices in Medical Device Market (2010)

List of Tables:

  • Table 5-1: Hospital Beds Ratio of Selected Countries (per ‘000 Population)
  • Table 5-2: Number of MOH Hospitals by Specialty (2009)
  • Table 5-3: Number of MOH Hospital Beds by Specialty (2009)
  • Table 5-4: Number of Other Government Hospital Beds by Specialty (2009)
  • Table 5-5: Number of Private Healthcare Facilities by Type (2009)
  • Table 5-6: Number of Private Hospital Beds by Specialty (2009)
  • Table 5-7: Number of Private Clinics by Specialty (2009)
  • Table 5-8: Average Length of Stay in Different Types of Hospitals
  • Table 5-9: Number of Physicians by Sector (2008 & 2009)
  • Table 5-10: Number of Nurses by Sector (2008 & 2009)
  • Table 5-11: Number of Allied Health Workers by Sector (2008 & 2009)
  • Table 6-1: Share of Top Ten Drugs in Pharmaceutical Market by Sales Value (Q3 2007)
  • Table 6-2: Share of Top Ten Drugs in Pharmaceutical Market by Sales Volume (Q3 2007)
  • Table 6-3: Share of Top Ten Players in Pharmaceutical Market by Sales Value (Q3 2007)
Back to Top